A Senate health committee has sent the AMA another letter demanding details on how it maintains and licenses the CPT code set, building on a probe launched in October.
North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...